A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Clinical trial NCT07465835 · RECRUITING

Trial details

NCT number: NCT07465835
Sponsor: Electra Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T Cell Malignancies

Start date: 2026-02-17
Primary completion: 2028-06-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.